netFormulary
 Report : A-Z HCD items in Formulary 15/08/2020 03:10:07
[Back]
 
Section Status BlueTeq Name
10.01.03 Restricted Use BlueTeq Abatacept Orencia®
01.05.03 Restricted Use BlueTeq Adalimumab Amgevita®, Humira®, Imraldi®
10.01.03 Restricted Use BlueTeq Adalimumab Amgevita®, Humira®, Imraldi®
13.05.03 Restricted Use BlueTeq Adalimumab Amgevita®,Humira®, Imraldi®
02.12 Restricted Use BlueTeq Alirocumab 
13.05.01 Restricted Use BlueTeq Alitretinoin Toctino®
10.01.03 Restricted Use BlueTeq Anakinra Kineret®
10.01.03 Restricted Use BlueTeq Apremilast Otezla®
13.05.03 Restricted Use BlueTeq Apremilast Otezla®
09.08.01 Restricted Use BlueTeq Asfotase alfa Strensiq®
08.01.05 Restricted Use BlueTeq Atezolizumab Tecentriq®
10.01.03 Restricted Use BlueTeq Baricitinib Olumiant®
05.01.09 Restricted Use BlueTeq Bedaquiline Sirturo®
03.04.02 Restricted Use BlueTeq Benralizumab Fasenra®
04.09.03 Restricted Use BlueTeq Botulinum Toxin Dysport®, Botox®, Neurobloc®,
04.07.04.02 Restricted Use BlueTeq Botulinum Toxin Type A botox®
07.04.02 Restricted Use BlueTeq Botulinum toxin type A  
13.12 Restricted Use BlueTeq Botulinum toxin type A  
08.01.05 Restricted Use BlueTeq Brentuximab vedotin Adcetris®
10.01.03 Restricted Use BlueTeq Certolizumab Pegol Cimzia®
06.01.06 Restricted Use BlueTeq Continuous Glucose Monitoring (CGM) System 
08.01.05 Restricted Use BlueTeq Crizotinib Xalkori®
13.05.01 Restricted Use BlueTeq Dupilumab Dupixent®
09.01.04 Restricted Use BlueTeq Eltrombopag Revolade®
02.11 Restricted Use BlueTeq Emicizumab Hemlibra®
10.01.03 Restricted Use BlueTeq Etanercept Enbrel®,Benepali®
13.05.03 Restricted Use BlueTeq Etanercept Enbrel®, Benepali®
08.01.05 Restricted Use BlueTeq Everolimus Votubia®
02.12 Restricted Use BlueTeq Evolocumab 
06.01.06 Restricted Use BlueTeq Flash Glucose Scanning (FGS) System Freestyle Libre®
01.05.03 Restricted Use BlueTeq Golimumab Simponi®
10.01.03 Restricted Use BlueTeq Golimumab Simponi®
13.05.03 Restricted Use BlueTeq Guselkumab Tremfya®
01.05.03 Restricted Use BlueTeq Infliximab Flixabi®, Inflectra®
10.01.03 Restricted Use BlueTeq Infliximab Remsima®, Inflectra®, Remicade®, Flixabi®
13.05.03 Restricted Use BlueTeq Infliximab Remsima®, Inflectra®,Remicade® Flixabi®
08.01.05 Restricted Use BlueTeq Ixazomib Ninlaro®
10.01.03 Restricted Use BlueTeq Ixekizumab Taltz®
03.04.03 Restricted Use BlueTeq Lanadelumab Takhzyro®
08.02.04 Restricted Use BlueTeq Nivolumab Opdivo ®
08.01.05 Restricted Use BlueTeq Pembrolizumab Keytruda®
20 Restricted Use BlueTeq Remdesivir 
08.01.05 Restricted Use BlueTeq Ribociclib Kisqali®
13.05.03 Restricted Use BlueTeq Risankizumab Skyrizi®
10.01.03 Restricted Use BlueTeq Rituximab (rheumatology) MabThera®, Truxima®
09.01.04 Restricted Use BlueTeq Romiplostim Nplate®
10.01.03 Restricted Use BlueTeq Secukinumab Cosentyx®
13.05.03 Restricted Use BlueTeq Secukinumab Cosentyx®
13.05.03 Restricted Use BlueTeq Tildrakizumab Ilumetri®
10.01.03 Restricted Use BlueTeq Tocilizumab RoActemra®
20.01 Restricted Use BlueTeq Tocilizumab 
10.01.03 Restricted Use BlueTeq Tofacitinib Xeljanz®
01.05.03 Restricted Use BlueTeq Ustekinumab Stelara®
01.05.03 Non Formulary BlueTeq Ustekinumab Stelara®
10.01.03 Restricted Use BlueTeq Ustekinumab Stelara®
13.05.03 Restricted Use BlueTeq Ustekinumab 
Cambridgeshire and Peterborough